1. Wu, M.Y., Li, C.J., Hou, M.F., and Chu, P.Y., New insights into the role of inflammation in the pathogenesis of atherosclerosis, Int. J. Mol. Sci., 2017, vol. 18, no. 10, p. 2034.
2. Anderson, T.J., Gregoire, J., Hegele, R.A., et al., 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult, Can. J. Cardiol., 2013, vol. 29, no. 2, p. 151.
3. El Harchaoui, K., van der Steeg, W.A., Stroes, E.S., et al., Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women. The EPIC-Norfolk prospective population study, J. Am. Coll. Cardiol., 2007, vol. 49, no. 5, p. 547.
4. Salakhov, I.M., Anikhovskaya, I.A., Maiskii, I.A., et al., The normative data of systemic endotoxinemia as the basic element of role definition of lipopolysaccharides of gut organisms in general pathology, Patogenez, 2015, vol. 13, no. 1, p. 18.
5. Findlay, L., Desai, T., Heath, A., et al., Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354, Pharm. Biol. Sci. Notes, 2015, vol. 2015, p. 73.